| Literature DB >> 35062733 |
Eduardo García-Toledano1, Emilio López-Parra1, Antonio Cebrián-Martínez1, Ascensión Palomares-Ruiz1.
Abstract
In the process of vaccination against COVID-19, the problem of parents who do not want to vaccinate their school-age children has been evident. A conflict arises between two fundamental rights: the right to ideological freedom, privacy, and physical integrity of parents and minors who do not opt for vaccination; and the right to health of the rest of the children who attend the same school, provoking a social debate on the need to introduce regulatory changes that favor the mandatory imposition of vaccination in certain cases. This research offers an observational study through a cross-sectional design of a quantitative nature, in which one thousand people belonging to the education, health, and economy sectors from seventy-six countries of five continents have participated. The instrument used was a previously validated questionnaire: VACUNASEDUCA. It was considered essential to know the awareness of vaccination processes of professionals from essential social sectors. Therefore, the objectives were: to reflect on the measures of mandatory vaccination, to know the importance of teachers being able to demand a regulated vaccination card from students, to study the need for regulation by administrations of compliance with vaccines, and to analyze the importance of health education. It has been shown that women and those under thirty years of age are the least in favor of compulsory vaccination, with the health sector being the most defending of their demand, and with Europe with the lowest means. It is concluded that mandatory vaccination could be an acceptable tactical option to prevent high-risk situations.Entities:
Keywords: COVID-19; equity; health education; obligation; prevention; regulation; vaccination; vaccination cards; woman
Year: 2022 PMID: 35062733 PMCID: PMC8779074 DOI: 10.3390/vaccines10010073
Source DB: PubMed Journal: Vaccines (Basel) ISSN: 2076-393X
Figure 1Characteristics of the sample according to sex and sector.
Structure of the instrument in dimensions.
| Dimensions | Items |
|---|---|
| D1 = Awareness and regulation | 1–2 |
| D2 = Education and teachers | 3–4 to 5–6 |
| D3 = Regulation and obligation | 7–8 |
| D4 = Consequences and risks | 9–10–11–12 |
Count after application of the questionnaire.
| Scale ( | 95% CI | 95% CI | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dimension (D) | Item | 1 | 2 | 3 |
| M | Lower | Upper | SD | Lower | Upper |
| P01 | 26 | 174 | 800 | 1000 | 2.77 | 2.75 | 2.80 | 0.48 | 0.44 | 0.51 | |
| P02 | 14 | 132 | 854 | 1000 | 2.84 | 2.81 | 2.86 | 0.40 | 0.37 | 0.44 | |
| D1 = Awareness and regulation | D1t | 2.81 | 2.78 | 2.83 | 0.36 | 0.34 | 0.38 | ||||
| P03 | 34 | 131 | 835 | 1000 | 2.80 | 2.77 | 2.83 | 0.48 | 0.44 | 0.52 | |
| P04 | 27 | 152 | 821 | 1000 | 2.79 | 2.77 | 2.82 | 0.47 | 0.43 | 0.50 | |
| P05 | 35 | 139 | 826 | 1000 | 2.79 | 2.76 | 2.82 | 0.49 | 0.44 | 0.52 | |
| P06 | 35 | 74 | 891 | 1000 | 2.86 | 2.83 | 2.88 | 0.44 | 0.40 | 0.49 | |
| D2 = Education and teachers | D2t | 2.81 | 2.79 | 2.83 | 0.31 | 0.28 | 0.33 | ||||
| P07 | 616 | 183 | 201 | 1000 | 1.59 | 1.53 | 1.64 | 0.80 | 0.78 | 0.83 | |
| P08 | 701 | 240 | 59 | 1000 | 1.36 | 1.32 | 1.40 | 0.59 | 0.56 | 0.62 | |
| D3 = Regulation and obligation | D3t | 1.47 | 1.44 | 1.51 | 0.59 | 0.56 | 0.61 | ||||
| P09 | 791 | 174 | 35 | 1000 | 1.24 | 1.21 | 1.28 | 0.50 | 0.47 | 0.54 | |
| P10 | 828 | 149 | 23 | 1000 | 1.20 | 1.17 | 1.22 | 0.45 | 0.41 | 0.48 | |
| P11 | 840 | 143 | 17 | 1000 | 1.18 | 1.15 | 1.20 | 0.42 | 0.39 | 0.46 | |
| P12 | 836 | 147 | 17 | 1000 | 1.18 | 1.16 | 1.21 | 0.43 | 0.39 | 0.46 | |
| D4 = Consequences and risks | D4t | 1.20 | 1.18 | 1.23 | 0.41 | 0.37 | 0.44 | ||||
| Total | S3t | 2.05 | 2.04 | 2.06 | 0.22 | 0.20 | 0.23 | ||||
Sex count of the participating sample for dimension D3.
| SEX | ||||||||
|---|---|---|---|---|---|---|---|---|
| Man | Woman | |||||||
| Dimension (D) | Item | 1 | 2 | 3 | 1 | 2 | 3 |
|
| D3 = Regulation and obligation | P07 | 157 | 60 | 89 | 459 | 123 | 112 | 1000 |
| P08 | 193 | 87 | 26 | 508 | 153 | 33 | 1000 | |
ANOVA for independent samples based on sex for dimension D3.
| Man | 95% CI | Woman | 95% CI | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dimension (D) | Item | M | Lower-Upper | SD | Lower-Upper | M | Lower-Upper | SD | Lower-Upper | F |
| Eta2 | Direction |
| P07 | 1.78 | 1.68–1.88 | 0.87 | 0.83–0.90 | 1.50 | 1.44–1.56 | 0.76 | 0.72–0.79 | 26.02 | <0.01 | 0.03 | W < M | |
| P08 | 1.45 | 1.39–1.53 | 0.65 | 0.59–0.70 | 1.32 | 1.28–1.36 | 0.56 | 0.52–0.60 | 11.86 | <0.01 | 0.01 | W < M | |
| D3 = Regulation and obligation | D3t | 1.62 | 1.55–1.69 | 0.64 | 0.60–0.68 | 1.41 | 1.37–1.45 | 0.55 | 0.52–0.58 | 27.17 | <0.01 | 0.03 | W < M |
Count by age group of the participating sample for dimension D3.
| AGE | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Less than 30 | Between 30 and 44 | Between 45 and 59 | Greater than 60 | |||||||||||
| Dimension (D) | 1 | 2 | 3 | 1 | 2 | 3 | 1 | 2 | 3 | 1 | 2 | 3 |
| |
| D3 = Regulation and obligation | P07 | 297 | 26 | 40 | 188 | 83 | 77 | 120 | 71 | 76 | 11 | 3 | 8 | 1000 |
| P08 | 315 | 36 | 12 | 232 | 94 | 22 | 141 | 102 | 24 | 13 | 8 | 1 | 1000 | |
ANOVA for independent samples by age group for dimension D3.
| Item | M | E1 = <30 | SD | 95% CI | M | E2 = 30–44 | SD | 95% CI |
| Eta2 | Direction |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P07 | 1.29 | 1.22–1.36 | 0.65 | 0.58–0.72 | 1.68 | 1.60–1.77 | 0.81 | 0.77–0.85 | 0.00 | 0.08 | E1 < E2.E3 |
| P08 | 1.17 | 1.12–1.21 | 0.45 | 0.38–0.52 | 1.40 | 1.33–1.46 | 0.61 | 0.55–0.65 | 0.00 | 0.07 | E1 < E2 < E3 |
| D3t | 1.23 | 1.18–1.28 | 0.46 | 0.40–0.51 | 1.54 | 1.48–1.60 | 0.59 | 0.55–0.62 | 0.00 | 0.11 | E1 < E2 < E3.E4 |
| Item | M | E3 = 45–59 | SD | 95% CI | M | E4 = >60 | SD | 95% CI |
| Eta2 | Direction |
| P07 | 1.84 | 1.73–1.93 | 0.84 | 0.80–0.87 | 1.86 | 1.45–2.29 | 0.94 | 0.76–1.00 | 0.00 | 0.08 | E1 < E2.E3 |
| P08 | 1.56 | 1.48–1.64 | 0.65 | 0.60–0.70 | 1.45 | 1.22–1.73 | 0.60 | 0.43–0.75 | 0.00 | 0.07 | E1 < E2 < E3 |
| D3t | 1.70 | 1.62–1.78 | 0.63 | 0.59–0.67 | 1.66 | 1.39–1.96 | 0.64 | 0.48–0.77 | 0.00 | 0.11 | E1 < E2 < E3.E4 |
Note: L = lower; U = upper.
Count by sector of the participating sample for dimension D3.
| Sector | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Health | Education | Economy | |||||||||
| Dimension (D) | Item | 1 | 2 | 3 | 1 | 2 | 3 | 1 | 2 | 3 |
|
| D3 = Regulation | P07 | 302 | 123 | 129 | 255 | 32 | 42 | 59 | 28 | 30 | 1000 |
| P08 | 356 | 159 | 39 | 279 | 44 | 6 | 66 | 37 | 14 | 1000 | |
ANOVA for independent samples by sector for dimension D3.
| Item | M | Health | SD | 95% CI |
| Eta2 | Direction |
|---|---|---|---|---|---|---|---|
| P07 | 1.69 | 1.62–1.76 | 0.83 | 0.79–0.85 | 0.00 | 0.04 | S2 > S1.S3 |
| P08 | 1.43 | 1.38–1.48 | 0.62 | 0.58–0.66 | 0.00 | 0.05 | S2 > S1.S3 |
| D3t | 1.56 | 1.51–1.61 | 0.60 | 0.57–0.63 | 0.00 | 0.06 | S2 > S1.S3 |
| Item | M | Education | SD | 95% CI |
| Eta2 | Direction |
| P03 | 1.35 | 1.28–1.43 | 0.70 | 0.62–0.76 | 0.00 | 0.04 | S2 > S1.S3 |
| P04 | 1.17 | 1.13–1.22 | 0.42 | 0.36–0.48 | 0.00 | 0.05 | S2 > S1.S3 |
| D3t | 1.26 | 1.21–1.31 | 0.47 | 0.42–0.52 | 0.00 | 0.06 | S2 > S1.S3 |
| Item | M | Economy | SD | 95% CI |
| Eta2 | Direction |
| P03 | 1.75 | 1.60–1.91 | 0.84 | 0.77–0.89 | 0.00 | 0.04 | S2 > S1.S3 |
| P04 | 1.56 | 1.43–1.68 | 0.70 | 0.61–0.77 | 0.00 | 0.05 | S2 > S1.S3 |
| D3t | 1.65 | 1.53–1.77 | 0.66 | 0.59–0.72 | 0.00 | 0.06 | S2 > S1.S3 |
Note: L = lower; U = upper.
Human Development Index (HDI) count for dimension D3.
| HDI | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Very high | High | Medium | Low | |||||||||||
| Dimension (D) | 1 | 2 | 3 | 1 | 2 | 3 | 1 | 2 | 3 | 1 | 2 | 3 |
| |
| D3 = Regulation | P07 | 564 | 157 | 152 | 36 | 18 | 31 | 14 | 4 | 13 | 2 | 4 | 5 | 1000 |
| P08 | 638 | 190 | 45 | 37 | 38 | 10 | 21 | 6 | 4 | 5 | 6 | 0 | 1000 | |
ANOVA for independent samples by Human Development Index (HDI) for dimension D3.
| Item | M | Very high | SD | 95% CI | M | High | SD | 95% CI |
| Eta2 | Direction |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P07 | 1.53 | 1.48–1.58 | 0.77 | 0.74–0.80 | 1.94 | 1.74–2.13 | 0.89 | 0.83–0.94 | 0.00 | 0.04 | I1 < I2 < I3 < I4 |
| P08 | 1.32 | 1.28–1.36 | 0.57 | 0.53–0.61 | 1.68 | 1.54–1.83 | 0.68 | 0.58–0.75 | 0.00 | 0.03 | I1 < I3 < I4 < I2 |
| D3t | 1.42 | 1.39–1.47 | 0.57 | 0.54–0.60 | 1.81 | 1.68–1.94 | 0.60 | 0.53–0.66 | 0.00 | 0.05 | I1 < I3 < I2 < I4 |
| Item | M | Medium | SD | 95% CI | M | Low | SD | 95% CI |
| Eta2 | Direction |
| P07 | 1.97 | 1.65–2.29 | 0.95 | 0.84–1.00 | 2.27 | 1.80–2.73 | 0.79 | 0.45–0.98 | 0.00 | 0.04 | I1 < I2 < I3 < I4 |
| P08 | 1.45 | 1.22–1.70 | 0.72 | 0.51–0.87 | 1.55 | 1.25–1.86 | 0.52 | 0.38–0.55 | 0.00 | 0.03 | I1 < I3 < I4 < I2 |
| D3t | 1.71 | 1.50–1.92 | 0.62 | 0.48–0.72 | 1.91 | 1.55–2.25 | 0.58 | 0.32–0.71 | 0.00 | 0.05 | I1 < I3 < I2 < I4 |
Note: L = lower; U = upper.
Count by continent of the participating sample for dimension D3.
| Continent | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Europe | America | Asia | Africa | Oceania | |||||||||||||
| Dimension (D) | 1 | 2 | 3 | 1 | 2 | 3 | 1 | 2 | 3 | 1 | 2 | 3 | 1 | 2 | 3 |
| |
| D3 = Regulation and obligation | P07 | 558 | 146 | 126 | 29 | 24 | 40 | 14 | 5 | 21 | 14 | 8 | 13 | 1 | 0 | 1 | 1000 |
| P08 | 624 | 169 | 37 | 38 | 43 | 12 | 18 | 14 | 8 | 20 | 14 | 1 | 1 | 0 | 1 | 1000 | |
ANOVA for independent samples by continent for dimension D3.
| Item | M | Europe | SD | 95% CI | M | America | SD | 95% CI |
| Eta2 | Direction |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P07 | 1.48 | 1.43–1.53 | 0.74 | 0.71–0.78 | 2.12 | 1.94–2.29 | 0.86 | 0.79–0.91 | 0.00 | 0.09 | C1 < C2.C3.C4 |
| P08 | 1.29 | 1.26–1.33 | 0.54 | 0.51–0.58 | 1.72 | 1.59–1.86 | 0.68 | 0.60–0.75 | 0.00 | 0.07 | C1 < C2.C3 |
| D3t | 1.39 | 1.35–1.42 | 0.54 | 0.51–0.57 | 1.92 | 1.80–2.05 | 0.64 | 0.56–0.69 | 0.00 | 0.11 | C1 < C2.C3.C4 |
| Item | M | Asia | SD | 95% CI | M | Africa | SD | 95% CI |
| Eta2 | Direction |
| P07 | 2.18 | 1.87–2.45 | 0.93 | 0.83–0.98 | 1.97 | 1.68–2.29 | 0.89 | 0.78–0.96 | 0.00 | 0.09 | C1 < C2.C3.C4 |
| P08 | 1.75 | 1.51–2.00 | 0.78 | 0.63–0.87 | 1.46 | 1.27–1.66 | 0.56 | 0.46–0.66 | 0.00 | 0.07 | C1 < C2.C3 |
| D3t | 1.96 | 1.74–2.15 | 0.64 | 0.52–0.74 | 1.71 | 1.51–1.92 | 0.60 | 0.51–0.66 | 0.00 | 0.11 | C1 < C2.C3.C4 |
Note: L = lower; U = upper.
Number of respondents per country of the participating sample.
| Number of Respondents by Country | |||||||
|---|---|---|---|---|---|---|---|
| Country |
| Country |
| Country |
| Country |
|
| Albania | 3 | Chile | 4 | Guatemala | 3 | Mexico | 10 |
| Germany | 28 | China | 6 | Guinea | 4 | Montenegro | 2 |
| Andorra | 2 | Cyprus | 4 | Haiti | 1 | Mozambique | 1 |
| Angola | 5 | Colombia | 13 | Honduras | 2 | Paraguay | 2 |
| Arabia | 4 | Ivory Coast | 2 | India | 6 | Peru | 2 |
| Argelia | 2 | Cuba | 3 | Ireland | 9 | Poland | 1 |
| Argentina | 6 | Denmark | 8 | Islandic | 2 | Portugal | 19 |
| Australia | 2 | Ecuador | 6 | Israel | 3 | United Kingdom | 21 |
| Austria | 6 | United Arab Emirates | 1 | Italy | 27 | Russia | 2 |
| Bangladesh | 2 | Spain | 596 | Jamaica | 3 | South Africa | 3 |
| Belgium | 6 | USA | 17 | Japan | 4 | Sweden | 2 |
| Bolivia | 5 | Estonia | 1 | Jordanian | 2 | Switzerland | 11 |
| Bosnia- | 1 | Philippines | 5 | Leetonia | 1 | Thailand | 3 |
| Botswana | 1 | Finland | 4 | Lebanon | 3 | Tanzania | 1 |
| Brazil | 8 | France | 49 | Liberia | 2 | Turkey | 2 |
| Bulgaria | 6 | Gabon | 1 | Luxemburg | 6 | Ukraine | 1 |
| Cape Verde | 1 | Gambia | 1 | Morocco | 1 | Uganda | 2 |
| Cameroon | 4 | Georgia | 2 | Mauritius | 1 | Venezuela | 2 |
| Canada | 6 | Greece | 8 | Mauritania | 1 | Zimbabwe | 3 |
Country count of the participating sample for dimension D3.
| Dimension (D) | Item | Country |
| ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| D3 = Regulation and obligation | Germany | Spain | France | ||||||||
| 1 | 2 | 3 | 1 | 2 | 3 | 1 | 2 | 3 | |||
| P07 | 12 | 9 | 7 | 454 | 78 | 64 | 20 | 17 | 12 | 673 | |
| P08 | 14 | 11 | 3 | 502 | 87 | 7 | 29 | 16 | 4 | 673 | |
| Italy | Portugal | United Kingdom | |||||||||
| 1 | 2 | 3 | 1 | 2 | 3 | 1 | 2 | 3 | |||
| P07 | 12 | 11 | 4 | 11 | 4 | 4 | 12 | 6 | 3 | 67 | |
| P08 | 15 | 10 | 2 | 11 | 6 | 2 | 15 | 6 | 0 | 67 | |
| U.S.A. | |||||||||||
| 1 | 2 | 3 | |||||||||
| P07 | 2 | 3 | 12 | 17 | |||||||
| P08 | 5 | 6 | 6 | 17 | |||||||
| P07 | TOTAL | 757 | |||||||||
| P08 | TOTAL | 757 | |||||||||
ANOVA for independent samples by country (M, SD from Germany, Spain, France, Italy, Portugal, United Kingdom, and U.S.A.) for dimension D3.
| Item | M | Germany | SD | 95% CI | M | Spain | SD | 95% CI |
| Eta2 | Direction |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P07 | 1.821 | 1.50–2.15 | 0.82 | 0.64–0.92 | 1.346 | 1.30–1.40 | 0.66 | 0.61–0.71 | 0.00 | 0.11 | E < R < P < I < A.F < U |
| P08 | 1.607 | 1.36–1.88 | 0.69 | 0.50–0.81 | 1.169 | 1.14–1.20 | 0.41 | 0.36–0.45 | 0.00 | 0.13 | E < R < F < I.P < A < U |
| D3t | 1.714 | 1.45–1.98 | 0.70 | 0.56–0.79 | 1.258 | 1.22–1.29 | 0.44 | 0.40–0.47 | 0.00 | 0.16 | E < R < P < I < F < A < U |
| Item | M | France | SD | 95% CI | M | Italy | SD | 95% CI |
| Eta2 | Direction |
| P07 | 1.837 | 1.62–2.08 | 0.80 | 0.70–0.88 | 1.704 | 1.43–1.97 | 0.72 | 0.56–0.85 | 0.00 | 0.11 | E < R < P < I < A.F < U |
| P08 | 1.490 | 1.32–1.70 | 0.65 | 0.51–0.77 | 1.519 | 1.27–1.77 | 0.64 | 0.46–0.78 | 0.00 | 0.13 | E < R < F < I.P < A < U |
| D3t | 1.663 | 1.50–1.84 | 0.58 | 0.48–0.67 | 1.611 | 1.40–1.84 | 0.56 | 0.40–0.68 | 0.00 | 0.16 | E < R < P < I < F < A < U |
| Item | M | Portugal | SD | 95% CI | M | United Kingdom | SD | 95% CI |
| Eta2 | Direction |
| P07 | 1.632 | 1.27–2.00 | 0.83 | 0.52–0.97 | 1.571 | 1.25–1.94 | 0.75 | 0.47–0.91 | 0.00 | 0.11 | E < R < P < I < A.F < U |
| P08 | 1.526 | 1.24–1.83 | 0.70 | 0.45–0.86 | 1.286 | 1.10–1.50 | 0.46 | 0.31–0.51 | 0.00 | 0.13 | E < R < F < I.P < A < U |
| D3t | 1.579 | 1.29–1.89 | 0.67 | 0.45–0.80 | 1.429 | 1.22–1.66 | 0.51 | 0.31–0.62 | 0.00 | 0.16 | E < R < P < I < F < A < U |
| Item | M | USA | SD | 95% CI |
| Eta2 | Direction | ||||
| P07 | 2.588 | 2.22–2.92 | 0.71 | 0.29–0.93 | 0.00 | 0.11 | E < R < P < I < A.F < U | ||||
| P08 | 2.059 | 1.64–2.46 | 0.83 | 0.62–0.94 | 0.00 | 0.13 | E < R < F < I.P < A < U | ||||
| D3t | 2.324 | 1.97–2.65 | 0.71 | 0.43–0.86 | 0.00 | 0.16 | E < R < P < I < F < A < U |
Note: L = lower; U = upper.
Spearman’s matrix of non-parametric bivariate correlations.
| Age | Sex | HDI | Continent | Sector | Country | ||
|---|---|---|---|---|---|---|---|
| Age | Correlation Coefficient | 1.000 | 0.234 ** | 0.206 ** | 0.256 ** | −0.209 ** | 0.014 |
| Sig. (2-tailed) | <0.001 | <0.001 | <0.001 | <0.001 | 0.666 | ||
| Sex | Correlation Coefficient | 0.234 ** | 1.000 | 0.120 ** | 0.127 ** | −0.096 ** | −0.005 |
| Sig. (2-tailed) | <0.001 | <0.001 | <0.001 | 0.002 | 0.879 | ||
| HDI | Correlation Coefficient | 0.206 ** | 0.120 ** | 1.000 | 0.813 ** | −0.193 ** | 0.011 |
| Sig. (2-tailed) | <0.001 | <0.001 | <0.001 | <0.001 | 0.725 | ||
| Continent | Correlation Coefficient | 0.256 ** | 0.127 ** | 0.813 ** | 1.000 | −0.211 ** | <0.001 |
| Sig. (2-tailed) | <0.001 | <0.001 | <0.001 | <0.001 | 1.000 | ||
| Sector | Correlation Coefficient | −0.209 ** | −0.096 ** | −0.193 ** | −0.211 ** | 1.000 | −0.042 |
| Sig. (2-tailed) | <0.001 | 0.002 | <0.001 | <0.001 | 0.189 | ||
| Country | Correlation Coefficient | 0.014 | −0.005 | 0.011 | <0.001 | −0.042 | 1.000 |
| Sig. (2-tailed) | 0.666 | 0.879 | 0.725 | 1.000 | 0.189 |
** Correlation is significant at the 0.01 level (2-tailed).